A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD	Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autosomal dominant polycystic kidney disease, autosomal dominant polycystic liver disease, cystic kidney disease, hereditary disease, kidney disorder, polycystic kidney disease, urinary system disorder	Active, not recruiting	Phase 2 / Phase 3	2026-06-01		NCT05281328

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Camurus AB	3

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Bon Secours Richmond Community Hospital	Richmond	United States	1
Hannover Medical School	Hanover	Germany	19
Hospital of the University of Pennsylvania	Philadelphia	United States	142
Mayo Clinic	Rochester	United States	664
Mount Sinai Hospital	New York	United States	225
Radboud UMC, Department of Gastroenterology and Hepatology	Nijmegen	Netherlands	1
The New York Presbyterian Hospital	New York	United States	1
Universitaetsklinikum Müenster	Münster	Germany	1
University Hospitals KU Leuven	Leuven	Belgium	1
University of Texas Southwestern Medical Center	Dallas	United States	1
Universitätsklinikum Leipzig	Leipzig	Germany	41